11/5
11:23 am
fold
Amicus Therapeutics Q3 2024 Earnings Preview Nov. 05, 2024 11:20 AM ET By: Jaskiran Singh , SA News Editor [Seeking Alpha]
Low
Report
Amicus Therapeutics Q3 2024 Earnings Preview Nov. 05, 2024 11:20 AM ET By: Jaskiran Singh , SA News Editor [Seeking Alpha]
11/4
11:43 am
fold
Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know [Yahoo! Finance]
Low
Report
Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know [Yahoo! Finance]
11/1
07:00 am
fold
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
Low
Report
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
10/31
02:04 am
fold
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
10/28
07:00 am
fold
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
Medium
Report
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
10/23
02:07 am
fold
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
10/21
11:44 am
fold
Why Amicus Therapeutics (FOLD) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Amicus Therapeutics (FOLD) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
10/18
03:52 pm
fold
Amicus: Teva Settlement Clears Revenue Path Forward For Galafold [Seeking Alpha]
Low
Report
Amicus: Teva Settlement Clears Revenue Path Forward For Galafold [Seeking Alpha]
8/8/2024
07:00 am
fold
amicus therapeutics, inc.
BEAT
Report
14.9%
amicus therapeutics, inc.
5/9/2024
07:00 am
fold
amicus therapeutics, inc.
MISS
Report
-6.6%
amicus therapeutics, inc.
2/28/2024
07:00 am
fold
amicus therapeutics, inc.
BEAT
Report
-10.1%
amicus therapeutics, inc.
11/8/2023
07:00 am
fold
amicus therapeutics, inc.
BEAT
Report
0.4%
amicus therapeutics, inc.
11/4
06:24 pm
fold
Form 4 AMICUS THERAPEUTICS, For: Nov 01 Filed by: Campbell Bradley L
Medium
Report
Form 4 AMICUS THERAPEUTICS, For: Nov 01 Filed by: Campbell Bradley L
11/1
04:50 pm
fold
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
Low
Report
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
10/17
07:01 am
fold
Form 8-K AMICUS THERAPEUTICS, For: Oct 15
High
Report
Form 8-K AMICUS THERAPEUTICS, For: Oct 15
10/7
01:25 pm
fold
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: JPMORGAN CHASE & CO
Neutral
Report
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: JPMORGAN CHASE & CO
10/4
04:06 pm
fold
Form 4 AMICUS THERAPEUTICS, For: Oct 01 Filed by: Campbell Bradley L
Low
Report
Form 4 AMICUS THERAPEUTICS, For: Oct 01 Filed by: Campbell Bradley L
10/1
04:35 pm
fold
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
Low
Report
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
9/5
05:01 pm
fold
Form 4 AMICUS THERAPEUTICS, For: Sep 03 Filed by: Campbell Bradley L
Low
Report
Form 4 AMICUS THERAPEUTICS, For: Sep 03 Filed by: Campbell Bradley L
9/3
04:19 pm
fold
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
Medium
Report
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
4/2
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
8.5%
2/4
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock, up previously from $19.00.
7.0%
3/9
Form 4 AMICUS THERAPEUTICS, For: Mar 05 Filed by: Campbell Bradley L
6.9%
2/4
Form 4 AMICUS THERAPEUTICS, For: Jan 31 Filed by: Crowley John F
6.5%
6/17
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
5.8%
1/14
Form 4 AMICUS THERAPEUTICS, For: Jan 10 Filed by: Barth Jay
5.4%
10/3
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) A Volatile Stock? [Yahoo! Finance News]
4.8%
3/24
Form 4 AMICUS THERAPEUTICS, For: Mar 20 Filed by: Crowley John F
4.4%
7/17
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was given a new $18.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
4.4%
4/24
Amicus Therapeutics to Announce First Quarter 2020 Financial Results on May 7, 2020
4.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register